Drug Approval | July 15, 2025
Zydus receives final approval from USFDA for Celecoxib Capsules
Celecoxib is a nonsteroidal anti-inflammatory drug
Celecoxib is a nonsteroidal anti-inflammatory drug
It is intended for contrast enhancement in MRI scans
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
Rifaximin tablets had annual sales of US$ 2672.9 mn in the United States (IQVIA MAT March 2025)
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Isotretinoin capsules are indicated to treat severe, disfiguring nodular acne
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
Glatiramer Acetate is the generic version of Copaxone 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
Subscribe To Our Newsletter & Stay Updated
